|

Concurrent Chemo/Radiation Therapy (cCRT): Paclitaxel Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Johnson & Johnson Enterprise Innovation Inc.1

Indications

  • Carcinoma, Non-Small-Cell Lung1
  • Lung Cancer1
  • Cancer1

Farmington, Connecticut1 trial

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

University of Connecticut Health Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.